Further, it was previously shown that AhR target genes CYP1A1, and to a lesser extent CYP1A2 and CYP1B1 are upregulated in response to AF treatment, and may play role in the metabolism of AF itself [7,8,17,19-21,25]. This evidence concerns the gene CYP1A2 and atrial fibrillation.